De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly

The recent World Health Organization (WHO) classification defines mantle cell lymphoma (MCL) as a distinct entity characterized by a unique immunophenotype and a molecular hallmark of chromosomal translocation t(11;14)(q13;q32). We report an unusual case of an advanced stage of CD5 negative MCL wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Ghaleb Elyamany, Ali Matar Alzahrani, Eman Al Mussaed, Hassan Aljasem, Sultan Alotaibi, Hatem Elghezal
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2015/146598
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850223513803161600
author Ghaleb Elyamany
Ali Matar Alzahrani
Eman Al Mussaed
Hassan Aljasem
Sultan Alotaibi
Hatem Elghezal
author_facet Ghaleb Elyamany
Ali Matar Alzahrani
Eman Al Mussaed
Hassan Aljasem
Sultan Alotaibi
Hatem Elghezal
author_sort Ghaleb Elyamany
collection DOAJ
description The recent World Health Organization (WHO) classification defines mantle cell lymphoma (MCL) as a distinct entity characterized by a unique immunophenotype and a molecular hallmark of chromosomal translocation t(11;14)(q13;q32). We report an unusual case of an advanced stage of CD5 negative MCL with a blastoid variant with a massive bone marrow (BM) necrosis as an initial presenting feature, with no adenopathy or hepatosplenomegaly. The pathologic features showed blastoid variant of MCL and flow cytometry showed that the tumor cells were CD5−, CD19+, CD20+, FMC-7+, CD23−, and lambda light chain restricted. Chromosomal analysis, using karyotype and fluorescent in situ hybridization (FISH), demonstrated karyotypic abnormalities in addition to the t(11;14). Our case study may be reported as a unique case of CD5− blastic MCL with unusual presentation and findings which made the diagnosis of MCL difficult.
format Article
id doaj-art-49634086d3bf45a0ba091ed5ea0e105b
institution OA Journals
issn 2090-6560
2090-6579
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Case Reports in Hematology
spelling doaj-art-49634086d3bf45a0ba091ed5ea0e105b2025-08-20T02:05:56ZengWileyCase Reports in Hematology2090-65602090-65792015-01-01201510.1155/2015/146598146598De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or OrganomegalyGhaleb Elyamany0Ali Matar Alzahrani1Eman Al Mussaed2Hassan Aljasem3Sultan Alotaibi4Hatem Elghezal5Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, P.O. Box 7897, Riyadh 11159, Saudi ArabiaDepartment of Oncology, Prince Sultan Military Medical City, P.O. Box 7897, Riyadh 11159, Saudi ArabiaDepartment of Basic Science, Princess Nourah Bint Abdulrahman University, College of Medicine, Riyadh, Saudi ArabiaDepartment of Adult Clinical Hematology and Stem Cell Therapy, Prince Sultan Military Medical City, P.O. Box 7897, Riyadh 11159, Saudi ArabiaDepartment of Adult Clinical Hematology and Stem Cell Therapy, Prince Sultan Military Medical City, P.O. Box 7897, Riyadh 11159, Saudi ArabiaDepartment of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, P.O. Box 7897, Riyadh 11159, Saudi ArabiaThe recent World Health Organization (WHO) classification defines mantle cell lymphoma (MCL) as a distinct entity characterized by a unique immunophenotype and a molecular hallmark of chromosomal translocation t(11;14)(q13;q32). We report an unusual case of an advanced stage of CD5 negative MCL with a blastoid variant with a massive bone marrow (BM) necrosis as an initial presenting feature, with no adenopathy or hepatosplenomegaly. The pathologic features showed blastoid variant of MCL and flow cytometry showed that the tumor cells were CD5−, CD19+, CD20+, FMC-7+, CD23−, and lambda light chain restricted. Chromosomal analysis, using karyotype and fluorescent in situ hybridization (FISH), demonstrated karyotypic abnormalities in addition to the t(11;14). Our case study may be reported as a unique case of CD5− blastic MCL with unusual presentation and findings which made the diagnosis of MCL difficult.http://dx.doi.org/10.1155/2015/146598
spellingShingle Ghaleb Elyamany
Ali Matar Alzahrani
Eman Al Mussaed
Hassan Aljasem
Sultan Alotaibi
Hatem Elghezal
De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly
Case Reports in Hematology
title De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly
title_full De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly
title_fullStr De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly
title_full_unstemmed De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly
title_short De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly
title_sort de novo cd5 negative blastic mantle cell lymphoma presented with massive bone marrow necrosis without adenopathy or organomegaly
url http://dx.doi.org/10.1155/2015/146598
work_keys_str_mv AT ghalebelyamany denovocd5negativeblasticmantlecelllymphomapresentedwithmassivebonemarrownecrosiswithoutadenopathyororganomegaly
AT alimataralzahrani denovocd5negativeblasticmantlecelllymphomapresentedwithmassivebonemarrownecrosiswithoutadenopathyororganomegaly
AT emanalmussaed denovocd5negativeblasticmantlecelllymphomapresentedwithmassivebonemarrownecrosiswithoutadenopathyororganomegaly
AT hassanaljasem denovocd5negativeblasticmantlecelllymphomapresentedwithmassivebonemarrownecrosiswithoutadenopathyororganomegaly
AT sultanalotaibi denovocd5negativeblasticmantlecelllymphomapresentedwithmassivebonemarrownecrosiswithoutadenopathyororganomegaly
AT hatemelghezal denovocd5negativeblasticmantlecelllymphomapresentedwithmassivebonemarrownecrosiswithoutadenopathyororganomegaly